Profil
William Murphy is associated with Dianomi Therapeutics, Inc. as the founder.
He holds the title of Chief Scientific Officer & Director since 2017.
Postes actifs de William Murphy
Sociétés | Poste | Début |
---|---|---|
Dianomi Therapeutics, Inc.
Dianomi Therapeutics, Inc. BiotechnologyHealth Technology Dianomi Therapeutics, Inc. engages in the development of Mineral Coated Microparticle (MCM) technology. It focuses on the improvement of drug molecules for targeting autoimmune diseases. The company was founded by Barry Kurokawa, William Murphy, Martin Ostrowski, and Anna Clements in 2017 and is headquartered in Madison, WI. | Fondateur | 01/01/2017 |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 1 |
---|---|
Dianomi Therapeutics, Inc.
Dianomi Therapeutics, Inc. BiotechnologyHealth Technology Dianomi Therapeutics, Inc. engages in the development of Mineral Coated Microparticle (MCM) technology. It focuses on the improvement of drug molecules for targeting autoimmune diseases. The company was founded by Barry Kurokawa, William Murphy, Martin Ostrowski, and Anna Clements in 2017 and is headquartered in Madison, WI. | Health Technology |